... consistent benefit includeindomethacin, somatostatin analogs, caffeine, ergotalkaloids, and nocturnal desmopressin. L-threo-3, 4- dihydroxyphenylserine is used in the rare but dis-tinctive entity, ... G. 1996. Chronic in ammatory demy-elinating polyneuropathy (CIDP) in diabetics. JNeurol Sci, 142 , 59– 64. Sumner, A.J. 19 94. Electrophysiology of the in am-matory demyelinating polyneuropathies. ... IIIchronic in ammatory demyelinating polyradicu-loneuropathy. Neurology, 56, 44 5–9.Midroni, G. and Dyck, P.J. 1996. Chronic in am-matory demyelinating polyradiculoneuropathy:Unusual clinical...